VRP.L Share News (VRP)
VRP Share
VRP Share
VRP Share
VRP Share
VRP
VRP Share
VRP Broker
VRP Directors
VRP Financial
VRP
VRP Short
VRPThu, 29th Oct 2020 19:09
Verona Pharma PLC - clinical-stage biopharmaceutical company - Pretax loss in third quarter ended September 30 widens to USD22.2 million from USD15.7 million a year earlier. For nine-months to September, loss stretches to USD47.1 million from USD38.7 million.
Current stock price: 51.00 pence
Year-to-date change: down 18%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
UK Earnings, Trading Statements Calendar - Next 7 Days
Read moreIN BRIEF: Verona Pharma To Delist From AIM But Remain On Nasdaq
Read moreIN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec
Read moreVerona Pharma Says Study Shows Ensifentrine Improves Lung Function
Read moreVerona Pharma Makes Progress In Phase Two Of Inhaler Clinical Trial
Read moreLONDON MARKET MIDDAY: Travel Stocks Suffer As UK Extends Quarantine
Read moreUK WINNERS & LOSERS SUMMARY: Airlines Hit As UK Quarantine List Grows
Read moreVerona To Trial Ensifentrine For Covid-19; First Half Loss Widens
Read moreLONDON MARKET PRE-OPEN: easyJet Raises Cash From Aircraft Sale
Read moreUK WINNERS & LOSERS SUMMARY: Verona Pharma Rises After Huge Fundraise
Read moreVerona Pharma Shares Surge As It Raises USD200 Million For Drug Trial
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreUK WINNERS & LOSERS SUMMARY: RBS Plummets As Dividend Lags Consensus
Read moreVerona Pharma Changes Top Management With New CEO, Finance Head
Read more
